StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca emerging Markets excluding China — Total revenue ($M) ($M)

Form 6-K Quarterly & Form 20-F Regional Revenue Table

QuarterlyAnnual
Latest, Q2 2026
2,334
Period ended Jun 30, 2026
Change on a year earlier
+14.2%
2,043 in Q2 2025
History
23 quarters
Since Q4 2020
Sources
23
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEmerging Markets excluding China — Total revenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20262,334+14.2%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20262,475+15.8%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20252,271+28.3%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20252,196+25.3%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20252,043+16.3%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20252,138+7.8%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20241,770+26.3%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20241,752+15.8%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20241,756+4.9%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20241,984+29.3%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20231,401-8.9%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20231,513+15.0%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20231,674+23.4%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20231,534+21.9%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20221,538-34.6%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20221,316-21.2%Form 6-K FY2022Q3 Earnings Release ↗

Breakdown

What makes up emerging markets excluding china — total revenue ($m)

Cite this data

StockData. (2026). AstraZeneca Emerging Markets excluding China — Total revenue ($M) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rev_reg_em_ex_china

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.